Vaccination is Important to Your Kids - an insight from Hilleman Labs - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Vaccination is Important to Your Kids - an insight from Hilleman Labs

Description:

Hilleman Laboratories is a joint-venture between Merck & Co., a global research-driven pharmaceutical company and Wellcome Trust, a global charitable foundation dedicated to achieving extraordinary improvements in Child Health Care. – PowerPoint PPT presentation

Number of Views:131

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Vaccination is Important to Your Kids - an insight from Hilleman Labs


1
Our commitment to Global Health
2
WELCOME TO HILLEMAN LABORATORIES
Bridging scientific research and industry to
develop effective, affordable and sustainable
vaccines for developing world.
3
Developing Vaccines for Global Health
4
Tomorrow... is our concern and we care
5
Developing immunity.. Promising well being
6
Life is precious.. Vaccination to preserve it
7
Protecting life and ensuring healthy growth
8
Affordable and accessible vaccines for the
developing nations
9
OUR IDENTITY
Hillemanlabs _at_ Nanotechnology Building, Jamia
Hamdard
10
DR. MAURICE HILLEMAN
A Pioneer in Vaccine Development
"Discoveries of the cause for diseases and their
prevention by vaccines... have been a hallmark
for twentieth century medicine and provide a
remarkable heritage for the people of the future."
Maurice R.Hilleman, PhD, DSc Senior Vice
President, 1957-1984 Merck Sharp Dohme Research
Laboratories
11
OUR APPROACH
HL carries out RD and Clinical Assessment
activities to develop vaccines for diseases that
constitute almost 90 of the global burden of
diseases
HL is forging partnerships with Government,
Policy Makers, Public Private Enterprises,
Research Institutes and NGOs to strengthen public
health systems and immunization programs
12
OUR APPROACH
13
OUR VISION
14
OUR DREAM
Vaccine for every child
Immunize and protect
Healthier force of tomorrow
15
OUR COMMITMENT
Facility (GLP class)
Scientists
Infrastructure
Novel Immunization Platform (HL)
16
OUR ADVISORS
Mr. Michel Greco
Professor Helen Rees OBE MB BChir, MA (CANTAB),
MRCGP, DCH, DRCOG
Former President of Aventis Pasteur
17
OUR BOARD MEMBERS
18
OUR MANAGEMENT
19
VACCINE RESEARCH OVERVIEW
01
02
03
04
05
06
07
08
20
VACCINE RESEARCH OVERVIEW
Hilleman Laboratories works extensively to bridge
the gap between current vaccine candidate
reliance on cold chain and low accessibility
build a new platform technology for development
of thermo-stable and affordable vaccines
21
RD AT HILLEMAN LABORATORIES
22
RD AT HILLEMAN LABORATORIES
Microbial and Mammalian culture
Filtration and chromatographic separation
Formulation development and lyophilization/spray-
dryiing
23
RD AT HILLEMAN LABORATORIES
24
RD AT HILLEMAN LABORATORIES
HL Lead Project
Research Proposal (from extramural, intramural,
biotech, foundation)
HL Scientific Advisory Leadership Projects
adopted
Review Review Strengths, Weakness
HL Leadership Program Plan
25
RD AT HILLEMAN LABORATORIES
26
OUR CULTURE
27
Latest happenings
Best Industrial Partnership in India
28
HOW WE PERCEIVE THE FUTURE
29
HILLEMAN LABORATORIES PVT. LTD.
Office Contact
About PowerShow.com